EXEL forecast price

Exelixis (EXEL) is expected to have a positive outlook with a potential increase in its stock price. Here's a detailed analysis:

1. **Current Price and Analyst Ratings**:
- Exelixis' current stock price is $43.62.
- The consensus rating for EXEL is "Buy" with an average current price target from analysts of $48.45.

2. **Price Target Ranges and Upside Potential**:
- Analysts have set a high price target of $51, which would represent a 16.78% upside potential from the current price.
- Other analysts have raised price targets to $50, indicating a 14.50% upside potential.
- Truist has increased its price target to $55, suggesting a 26.38% upside potential.
3. **Market Performance and Recent News**:
- Exelixis has seen a strong financial performance and a positive earnings outlook, which is driving its high stock score.
- The company has also experienced an upgrade in its rating and increased price target from Stephens, with the new target set at $60.
- The successful results of the STELLAR-303 trial have boosted investor confidence in Exelixis' future prospects.
4. **Potential Challenges and Risks**:
- Exelixis faces risks related to product approvals and regulatory issues, which could impact its stock price.
- The company's gross to net deductions increased in the first quarter due to higher PHS and 340B volumes.

In conclusion, based on the analyst price targets, market performance, and recent news, Exelixis (EXEL) is expected to have a positive outlook with potential for an increase in its stock price. However, investors should be aware of potential challenges and risks that could impact the stock's performance.